CY1115230T1 - DERIVATIVE ISOLINDINO-1,3-DIONION DERIVATIVES AS PDE4 AND TNF-ALPHA INHIBITORS - Google Patents

DERIVATIVE ISOLINDINO-1,3-DIONION DERIVATIVES AS PDE4 AND TNF-ALPHA INHIBITORS

Info

Publication number
CY1115230T1
CY1115230T1 CY20141100396T CY141100396T CY1115230T1 CY 1115230 T1 CY1115230 T1 CY 1115230T1 CY 20141100396 T CY20141100396 T CY 20141100396T CY 141100396 T CY141100396 T CY 141100396T CY 1115230 T1 CY1115230 T1 CY 1115230T1
Authority
CY
Cyprus
Prior art keywords
derivatives
isolindino
dionion
pde4
tnf
Prior art date
Application number
CY20141100396T
Other languages
Greek (el)
Inventor
Julie F Liu
Original Assignee
Concert Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10727607.3A external-priority patent/EP2443089B1/en
Application filed by Concert Pharmaceuticals Inc. filed Critical Concert Pharmaceuticals Inc.
Publication of CY1115230T1 publication Critical patent/CY1115230T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η εφεύρεση αυτή αφορά σε νέα παράγωγα υποκατεστημένης ισοϊνδολινο-1,3-διόνης και φαρμακευτικώς αποδεκτά άλατα αυτών. Ειδικότερα, η εφεύρεση αφορά σε νέα παράγωγα υποκατεστημένης ισοϊνδολινο-1,3-διόνης που είναι ανάλογα της απρεμιλάστης. Η εφεύρεση αυτή παρέχει επίσης συνθέσεις που περιλαμβάνουν μία ένωση της εφεύρεσης αυτής και ένα φορέα και τη χρήση των αποκαλυπτόμενων ενώσεων και συνθέσεων σε μεθόδους θεραπείας ασθενειών και καταστάσεων που θεραπεύονται ευεργετικώς με χορήγηση απρεμιλάστης.This invention relates to novel substituted isoindolin-1,3-dione derivatives and their pharmaceutically acceptable salts. In particular, the invention relates to novel substituted isoindolin-1,3-dione derivatives that are analogous to aprilmast. This invention also provides compositions comprising a compound of this invention and a carrier and the use of the disclosed compounds and compositions in methods of treating diseases and conditions that are beneficial in the treatment of apremilast.

CY20141100396T 2009-06-18 2014-06-04 DERIVATIVE ISOLINDINO-1,3-DIONION DERIVATIVES AS PDE4 AND TNF-ALPHA INHIBITORS CY1115230T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26895309A 2009-06-18 2009-06-18
EP10727607.3A EP2443089B1 (en) 2009-06-18 2010-06-15 Deuterated isoindoline-1,3-dione derivatives as pde4 and tnf-alpha inhibitors

Publications (1)

Publication Number Publication Date
CY1115230T1 true CY1115230T1 (en) 2017-01-04

Family

ID=58461541

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100396T CY1115230T1 (en) 2009-06-18 2014-06-04 DERIVATIVE ISOLINDINO-1,3-DIONION DERIVATIVES AS PDE4 AND TNF-ALPHA INHIBITORS

Country Status (1)

Country Link
CY (1) CY1115230T1 (en)

Similar Documents

Publication Publication Date Title
CY1121858T1 (en) ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS CONTAINING THEM AND METHODS OF USING THEM
CY1120866T1 (en) DNA-PK INHIBITORS
CY1122707T1 (en) HETEROCYCLIC GLUTAMINASE INHIBITORS
CY1121357T1 (en) NEW IMMUNODATER AND ANTI-INFLAMMATORY COMPOUNDS
CY1119056T1 (en) 2 ', 4', - DIFFluoro-2'-Methyl-Substituted Nucleoside Derivatization as HCV RNA Replication Inhibitors
CY1121040T1 (en) ANTIQUE TREATMENT
CY1124000T1 (en) SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES IN CRYSTALLINE FORM
CL2011000957A1 (en) Compound substituted isoindoline derivatives, tnf-a cytosine inhibitors; pharmaceutical composition; Useful in the treatment of cancer.
CY1121450T1 (en) COMBINATION TREATMENT FOR CANCER TREATMENT
EA201100447A1 (en) ORGANIC COMPOUNDS
CO6480927A2 (en) DERIVATIVES OF IMIDAZOLIN-2-ONA 1,3-DISUSTITUTED AS CYP17 INHIBITORS.
EA201100750A1 (en) SUBSTITUTED DIOXOPIPERIDINYL-PHTHALIMIDE DERIVATIVES
CY1117584T1 (en) 1-Benzyl-3-hydroxymethyldazole derivative and their use in the therapeutic treatment of MCP-1-expressing MC3-C3
CY1118362T1 (en) Piperidinone Cyanide CGRP Receptor Competitors
CR11803A (en) PIRROLOPIRIDINS AS CINASE INHIBITORS
ECSP13012417A (en) NAPHT-2-ILACETIC ACID DERIVATIVES TO TREAT AIDS
EA201200473A1 (en) SUBSTITUTED (HETEROARILMETHYL) THIOGIDANTOINES
EA201270043A1 (en) SUBSTITUTED DERIVATIVES OF ISOINDOLIN-1,3-DIONA
EA201270752A1 (en) KINASE INHIBITORS AND METHOD FOR TREATING MALIGNANT TUMOR WITH THEIR HELP
CY1117562T1 (en) TRIAZOLOPYRIDES AS PHOSPHODESTERATION INHIBITORS FOR TREATMENT OF SKIN DISEASES
CY1117504T1 (en) 1-Benzyl-3-hydroxymethyldazole derivative and their use in the therapeutic treatment of MCP-1 and MCP-1-expressing diseases
GT201200138A (en) USEFUL HETEROCYCLIC SULFONAMIDE DERIVATIVES AS MEK INHIBITORS
BR112018068412A2 (en) compound, pharmaceutical composition, method of treating myelodysplastic syndrome and method for killing a tumor cell
EA201000895A1 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIZOSOME DISEASES
SG195257A1 (en) Anti-thrombotic compounds